Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scienti

The Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scienti conducts focused research on cardiovascular diseases, aiming to improve treatment options for patients with serious heart conditions. Current studies assess new therapeutic agents to reduce disease progression and enhance quality of life.

• Heart failure due to systemic left ventricular systolic dysfunction
• Transthyretin‑Mediated Amyloid Cardiomyopathy (ATTR‑CM)
• Efficacy and safety of vericiguat in heart failure
• Long‑term outcomes of ION‑682884 in ATTR‑CM patients

With two active trials overseen by a team of two investigators, the department in Bologna, Italy is evaluating novel drugs to lower biomarkers such as NT‑proBNP and to prevent cardiovascular death and recurrent events. These efforts reflect a commitment to advancing care for individuals living with advanced cardiac disease.